Form 4: EcoR1 Capital Increases Stake in Zymeworks Inc. Through Open Market Purchases

EcoR1 Capital, a significant shareholder in Zymeworks Inc., has increased its holdings through a series of open market purchases between March 20-24, 2025.

Summary

• EcoR1 Capital, LLC, along with Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P., have reported changes in their beneficial ownership of Zymeworks Inc. common stock.
• Between March 20 and March 24, 2025, EcoR1 Capital Fund Qualified, L.P. purchased a total of 127,298 shares of Zymeworks Inc. common stock through a series of transactions.
• The purchases were made at prices ranging from $12.6895 to $13.0833 per share.
• Following these transactions, EcoR1 Capital Fund Qualified, L.P. directly held 16,083,196 shares.
• EcoR1 Capital, as the investment advisor to the Funds, and Oleg Nodelman, as the control person of EcoR1, may be deemed to indirectly beneficially own these shares.
• The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The increased investment by EcoR1 Capital could be seen as a vote of confidence, but it's a routine transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• Increased investment by a major shareholder could be interpreted as a positive signal regarding the company's prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell shares. This filing indicates increased ownership by EcoR1 Capital, which could be seen as a sign of confidence in Zymeworks' future prospects.

Comparison to Industry Standards

• It's common for investment firms specializing in biotechnology, such as EcoR1 Capital, to actively manage their positions in portfolio companies like Zymeworks.
• Similar firms like OrbiMed Advisors or RA Capital Management often make similar moves, increasing or decreasing their stakes based on their assessment of the company's performance and prospects.
• The size of the stake and the frequency of transactions are typical for firms with significant holdings.

Stakeholder Impact

• The increased stake by EcoR1 Capital could positively influence shareholder confidence.

Key Dates

Keywords

Zymeworks, EcoR1 Capital, Beneficial Ownership, Stock Purchase, Form 4, Shareholding